Lena obtained her PhD at the Medicinal Chemistry Department at the Biomedical Centre at Uppsala University, Sweden. Following a postdoc in combinatorial chemistry at the University of Pittsburgh she joined AstraZeneca, Lund as a Senior Research Scientist in Medicinal Chemistry in 2000. Lena has experience from projects in all stages of preclinical research addressing a range of different targets classes in the discovery of new drugs for the treatment of chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Since 2019, she is Director in Medicinal Chemistry, in the Respiratory & Immunology unit at AstraZeneca in Gothenburg, Sweden. Her current role includes leading a team of medicinal chemists as well as leading projects aimed both at oral and inhaled delivery.